112 related articles for article (PubMed ID: 16700519)
1. Possible role of DP IV inhibitors in acne therapy.
Thielitz A; Reinhold D; Vetter R; Lendeckel U; Kähne T; Bank U; Helmuth M; Neubert K; Faust J; Hartig R; Wrenger S; Zouboulis CC; Ansorge S; Gollnick H
Adv Exp Med Biol; 2006; 575():163-7. PubMed ID: 16700519
[No Abstract] [Full Text] [Related]
2. Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation.
Thielitz A; Reinhold D; Vetter R; Bank U; Helmuth M; Hartig R; Wrenger S; Wiswedel I; Lendeckel U; Kähne T; Neubert K; Faust J; Zouboulis CC; Ansorge S; Gollnick H
J Invest Dermatol; 2007 May; 127(5):1042-51. PubMed ID: 16778789
[TBL] [Abstract][Full Text] [Related]
3. Is sebocyte-derived leptin the missing link between hyperseborrhea, ductal hypoxia, inflammation and comedogenesis in acne vulgaris?
Melnik BC
Exp Dermatol; 2016 Mar; 25(3):181-2. PubMed ID: 26660941
[No Abstract] [Full Text] [Related]
4. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S
Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521
[No Abstract] [Full Text] [Related]
5. Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM).
Hinke SA; Pederson RA; McIntosh CH
Adv Exp Med Biol; 2006; 575():119-33. PubMed ID: 16700515
[No Abstract] [Full Text] [Related]
6. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases.
Thielitz A; Ansorge S; Bank U; Tager M; Wrenger S; Gollnick H; Reinhold D
Front Biosci; 2008 Jan; 13():2364-75. PubMed ID: 17981718
[TBL] [Abstract][Full Text] [Related]
7. Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth.
Kitlinska J; Kuo L; Abe K; Pons J; Yu M; Li L; Tilan J; Toretsky J; Zukowska Z
Adv Exp Med Biol; 2006; 575():223-9. PubMed ID: 16700526
[No Abstract] [Full Text] [Related]
8. The role of CD26/DPP IV in preservation of early pulmonary graft function.
Jung FJ; Cardell M; Yang L; De Meester I; Augustyns K; Hillinger S; Scharpe S; Weder W; Korom S
Adv Exp Med Biol; 2006; 575():231-5. PubMed ID: 16700527
[No Abstract] [Full Text] [Related]
9. The sebocyte culture: a model to study the pathophysiology of the sebaceous gland in sebostasis, seborrhoea and acne.
Zouboulis CC; Schagen S; Alestas T
Arch Dermatol Res; 2008 Sep; 300(8):397-413. PubMed ID: 18690467
[TBL] [Abstract][Full Text] [Related]
10. DNA synthesis in cultured human keratinocytes and HaCaT keratinocytes is reduced by specific inhibition of dipeptidyl peptidase IV (CD26) enzymatic activity.
Vetter R; Reinhold D; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Ansorge S; Gollnick H
Adv Exp Med Biol; 2000; 477():167-71. PubMed ID: 10849744
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications.
Clarke SB; Nelson AM; George RE; Thiboutot DM
Dermatol Clin; 2007 Apr; 25(2):137-46, v. PubMed ID: 17430751
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes.
Im M; Kim SY; Sohn KC; Choi DK; Lee Y; Seo YJ; Kim CD; Hwang YL; Zouboulis CC; Lee JH
J Invest Dermatol; 2012 Dec; 132(12):2700-8. PubMed ID: 22763784
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities.
Park J; Ajami K; Yu DM; Gorrell MD
Adv Exp Med Biol; 2006; 575():93-102. PubMed ID: 16700512
[No Abstract] [Full Text] [Related]
14. Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y.
Li L; Demuth HU; Zukowska Z
Adv Exp Med Biol; 2006; 575():135-40. PubMed ID: 16700516
[No Abstract] [Full Text] [Related]
15. Potent inhibitors of dipeptidyl peptidase IV and their mechanisms of inhibition.
Stöckel-Maschek A; Stiebitz B; Born I; Faust J; Mögelin W; Neubert K
Adv Exp Med Biol; 2000; 477():117-23. PubMed ID: 10849737
[TBL] [Abstract][Full Text] [Related]
16. Physiopathology of acne vulgaris: recent data, new understanding of the treatments.
Pawin H; Beylot C; Chivot M; Faure M; Poli F; Revuz J; Dréno B
Eur J Dermatol; 2004; 14(1):4-12. PubMed ID: 14965788
[TBL] [Abstract][Full Text] [Related]
17. Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acne.
Chen W; Yang CC; Liao CY; Hung CL; Tsai SJ; Chen KF; Sheu HM; Zouboulis CC
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):846-52. PubMed ID: 16898909
[TBL] [Abstract][Full Text] [Related]
18. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
Del Rosso JQ; Schmidt NF
Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207
[TBL] [Abstract][Full Text] [Related]
19. Management of refractory acne.
Pochi PE
Hosp Pract (Off Ed); 1985 Oct; 20(10A):73-5, 79, 82. PubMed ID: 2932455
[No Abstract] [Full Text] [Related]
20. Phosphorus-containing inhibitors of proteolytic enzymes.
Stöckel-Maschek A; Stiebitz B; Senns B; Lindner N; Mögelin W; Neubert K
Adv Exp Med Biol; 2006; 575():19-26. PubMed ID: 16700504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
